UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Linde
LIN
|
+$940M |
| 2 |
Abbott
ABT
|
+$911M |
| 3 |
Amgen
AMGN
|
+$800M |
| 4 |
Pinduoduo
PDD
|
+$336M |
| 5 |
Advanced Micro Devices
AMD
|
+$289M |
Top Sells
| 1 |
Ametek
AME
|
+$485M |
| 2 |
Microsoft
MSFT
|
+$301M |
| 3 |
Amazon
AMZN
|
+$236M |
| 4 |
VMW
VMware, Inc
VMW
|
+$205M |
| 5 |
TSMC
TSM
|
+$143M |
Sector Composition
| 1 | Technology | 28.1% |
| 2 | Healthcare | 14.47% |
| 3 | Financials | 11.1% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Industrials | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Hanesbrands
HBI
$2.2B
| $2.99M | ﹤0.01% |
568,024
-17,981
| -3% | -$94.6K |
|
1402
Plexus
PLXS
$3.73B
| $2.98M | ﹤0.01% |
30,578
+3,494
| +13% | +$341K |
|
1403
Select Medical
SEM
$1.55B
| $2.98M | ﹤0.01% |
214,101
-3,172
| -1% | -$44.2K |
|
1404
Opendoor
OPEN
$6.68B
| $2.98M | ﹤0.01% |
1,694,012
-1,092,331
| -39% | -$1.92M |
|
1405
Itron
ITRI
$5.47B
| $2.98M | ﹤0.01% |
53,661
+2,182
| +4% | +$121K |
|
1406
Alight
ALIT
$1.95B
| $2.94M | ﹤0.01% |
319,391
+11,158
| +4% | +$103K |
|
|
RVNC
1407
DELISTED
Revance Therapeutics, Inc.
RVNC
| $2.93M | ﹤0.01% |
90,914
+11,928
| +15% | +$384K |
|
1408
Mercury Systems
MRCY
$4.34B
| $2.92M | ﹤0.01% |
57,130
-4,011
| -7% | -$205K |
|
1409
Omnicell
OMCL
$1.46B
| $2.91M | ﹤0.01% |
49,578
+4,051
| +9% | +$238K |
|
1410
Moelis & Co
MC
$5.54B
| $2.89M | ﹤0.01% |
+75,227
| New | +$2.89M |
|
1411
Corcept Therapeutics
CORT
$7.68B
| $2.89M | ﹤0.01% |
133,351
+3,447
| +3% | +$74.7K |
|
|
ESGR
1412
DELISTED
Enstar Group
ESGR
| $2.88M | ﹤0.01% |
12,444
+715
| +6% | +$166K |
|
1413
Leslie's
LESL
$62M
| $2.88M | ﹤0.01% |
261,789
+19,760
| +8% | +$218K |
|
1414
Civitas Resources
CIVI
$3.02B
| $2.87M | ﹤0.01% |
42,047
-952
| -2% | -$65.1K |
|
|
B
1415
DELISTED
Barnes Group Inc.
B
| $2.86M | ﹤0.01% |
+71,113
| New | +$2.86M |
|
1416
CVB Financial
CVBF
$2.77B
| $2.86M | ﹤0.01% |
171,689
-8,519
| -5% | -$142K |
|
1417
Alarm.com
ALRM
$2.78B
| $2.86M | ﹤0.01% |
+56,901
| New | +$2.86M |
|
1418
MYR Group
MYRG
$2.73B
| $2.84M | ﹤0.01% |
22,575
+1,331
| +6% | +$168K |
|
|
PRFT
1419
DELISTED
Perficient Inc
PRFT
| $2.84M | ﹤0.01% |
39,399
+3,183
| +9% | +$230K |
|
1420
Nu Skin
NUS
$596M
| $2.84M | ﹤0.01% |
72,279
+3,767
| +5% | +$148K |
|
1421
Alamo Group
ALG
$2.49B
| $2.84M | ﹤0.01% |
+15,428
| New | +$2.84M |
|
|
GMS
1422
DELISTED
GMS Inc
GMS
| $2.84M | ﹤0.01% |
49,055
+13,565
| +38% | +$785K |
|
|
ENV
1423
DELISTED
ENVESTNET, INC.
ENV
| $2.84M | ﹤0.01% |
48,326
+2,947
| +6% | +$173K |
|
1424
NETSCOUT
NTCT
$1.8B
| $2.84M | ﹤0.01% |
98,956
+7,430
| +8% | +$213K |
|
1425
Frontdoor
FTDR
$4.83B
| $2.83M | ﹤0.01% |
101,544
+5,285
| +5% | +$147K |
|